<DOC>
	<DOCNO>NCT02679443</DOCNO>
	<brief_summary>Folic acid ( FA ; folate ) dose 350-1,000 μg daily supplement , daily , start 7 day first dose pemetrexed base chemotherapy continue patient therapy 21 day cessation therapy . Vitamin B12 injection ( 1,000 μg i.m . ) also start 1 week first dose chemotherapy . However , evidence delay chemotherapy seven day purpose give vitamin B12 FA supplementation robust . Observational prospective single arm study show increased toxicity pemetrexed start earlier recommend duration supplementation . In resource constrain setting , lead one additional visit 1-week chemotherapy delay may inconvenient patient . Hence open label , randomize control trial undertaken evaluate difference pemetrexed related hematological toxicity amongst patient receive delay initiation chemotherapy ( follow 5 - 7 day vitamin B12 FA supplementation ; Delayed Arm ) compare vitamin B12 FA supplementation start simultaneously ( within 24 hour ) initiation chemotherapy ( Immediate Arm ) .</brief_summary>
	<brief_title>Vitamin Supplementation NSCLC Patients Pemetrexed Based Chemotherapy</brief_title>
	<detailed_description>Chemotherapy Regimen : All patient receive pemetrexed cisplatin dose 500 mg 65 mg , respectively , per square meter body surface area day 1 3-week cycle . Patients contraindication administration cisplatin , intolerant cisplatin , develop grade 3 4 adverse event cisplatin give carboplatin combination pemetrexed . Carboplatin give dose calculated produce area concentration-time curve ( AUC ) 5.0mg/mL/min . Dose modification either pemetrexed platinum agent do case significant change PS toxicity intolerance dose administer previous cycle . Supplementation : 1 . Folic acid ( FA ) supplementation give patient orally dose 5 ml ( 1000 μg ) daily VITCOFOL ( FDC Limited , Mumbai , India ) pediatric formulation , contain 200 μg FA/ml preparation . Patients instructed measure prescribe dose use 5 ml plastic syringe contain marking every 0.5 ml . Patients also instruct take additional multivitamin supplement . In addition FA supplementation , patient also start simultaneously oral iron ( ferrous sulphate 200 mg twice day ) . Once initiate , FA ferrous sulphate give daily basis continue throughout duration chemotherapy least 3 week beyond last cycle . 2 . Vitamin B12 supplementation give patient intramuscularly dose 1000 μg along cycle chemotherapy ( maximum six dos study period ) .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Thrombocytopenia</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin B 12</mesh_term>
	<mesh_term>Hydroxocobalamin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Locally advanced metastatic ( Stage IIIB/IV ) NSCLC Stage III A NSCLC , schedule upfront surgical resection Nonsquamous histology ( include adenocarcinoma ) At least one unidimensionally measurable lesion , accord Response Evaluation Criteria Solid Tumors ( RECIST , version 1.0 ) , least one nonmeasurable lesion assessable use conventional technique spiral compute tomography scan An Eastern Cooperative Oncology Group ( ECOG ) performance status 0 2 No previous chemotherapy advance disease previous target molecular therapy Adequate liver renal function ; Previous radiation therapy permit complete &gt; 4 week enrollment patient recover treatmentrelated toxicity . Hemoglobin value &lt; 9gm/dl Required erythropoiesis stimulate agent blood transfusion recent past ( 4 month ) Symptomatic untreated brain metastasis Any previous malignancy Concurrent use tumor therapy Active infection serious concomitant disorder Inability interrupt nonsteroidal antiinflammatory agent Inability unwillingness take folic acid , vitamin B12 , dexamethasone supplementation Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Lung Adenocarcinoma</keyword>
	<keyword>Non-squamous NSCLC</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>Pemetrexed</keyword>
	<keyword>Vitamin B12</keyword>
	<keyword>Folate</keyword>
	<keyword>Supplementation</keyword>
	<keyword>Cytopenia</keyword>
</DOC>